Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients

OBJECTIVE: The current research was to assess the relevance between depression disorder and first-line chemotherapy combined with immunotherapy, quality of life in patients with oncogene-driver negative non-small cell cancer (NSCLC). METHODS: NSCLC patients (33 with depression disorder and 34 with n...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, Bi, Ziran, Wu, Junxu, Duan, Xu, Pang, Lulian, Jing, Yanyan, Yin, Xiangxiang, Cheng, Huaidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359314/
https://www.ncbi.nlm.nih.gov/pubmed/35957880
http://dx.doi.org/10.3389/fonc.2022.772102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359314/
https://www.ncbi.nlm.nih.gov/pubmed/35957880
http://dx.doi.org/10.3389/fonc.2022.772102

Ejemplares similares